{"id":3769,"date":"2024-09-26T14:42:29","date_gmt":"2024-09-26T18:42:29","guid":{"rendered":"https:\/\/sites.bu.edu\/tpri\/?post_type=profile&#038;p=3769"},"modified":"2024-09-26T14:42:29","modified_gmt":"2024-09-26T18:42:29","slug":"keith-drake","status":"publish","type":"profile","link":"https:\/\/sites.bu.edu\/tpri\/profile\/keith-drake\/","title":{"rendered":"Keith Drake"},"content":{"rendered":"<p>Keith Drake is a Director at Greylock McKinnon Associates and a research fellow at Boston University TPRI.\u00a0 His consulting work and academic research are focused on brand-generic competition in the pharmaceutical industry.\u00a0 His research has been cited by multiple court rulings in antitrust lawsuits.\u00a0 A coauthored paper on reverse payment settlements won the best paper prize from the International Journal of the Economics of Business in 2016.\u00a0 He earned a Ph.D. in health policy from the Geisel School of Medicine at Dartmouth College.<\/p>\n","protected":false},"author":13705,"template":"","_links":{"self":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/profile\/3769"}],"collection":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/users\/13705"}],"version-history":[{"count":1,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/profile\/3769\/revisions"}],"predecessor-version":[{"id":3770,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/profile\/3769\/revisions\/3770"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/media?parent=3769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}